DC Discusses: The industry reset in Chemicals M&A

Global Chemicals M&A activity is shifting toward specialty assets with defensible market positions, as structural forces reshape the sector faster than the current economic cycle. The global Chemicals sector is navigating change that extends beyond current macroeconomic circumstances: the forces shaping investment outcomes are increasingly structural rather than cyclical, favouring investors with deep sector specialisation as broad-based exposure becomes harder to underwrite.

How is the Chemicals sector diverging by region?

Regional competitive positioning is diverging as a 50-year globalisation trend begins to reverse. The United States and Middle East are consolidating their upstream and midstream cost advantage through cheap feedstock and protective tariffs. Europe, by contrast, is undergoing significant rationalisation.

• European Union chemical capacity utilisation in 2025 ran approximately seven percentage points below the long-term average
• European gas prices remain roughly two to four times higher than in the United States
• More than 80% of announced global plant closures have occurred in Europe
• China added more than eight million tons of new polyethylene capacity last year alone, intensifying downward pricing pressure across global markets

Chemicals M&A is becoming more selective and bilateral

Large-scale auctions are giving way to targeted, thesis-driven processes, often following an unsolicited approach, with specialty assets that hold defensible market positions and domestic insulation commanding premium valuations. Large corporates are actively reshaping their portfolios, divesting non-core assets and concentrating resources on fewer, higher-quality segments, generating a sustained pipeline of carve-out and secondary opportunities for private equity investors.

Why is Chemicals M&A shifting toward specialty assets?

The divergence between attractive and challenged segments is becoming increasingly pronounced.

• Specialty chemicals with defensible pricing power, formulation expertise, and exposure to structurally growing end markets, such as advanced materials, electronics, nutrition and water treatment, continue to attract premium valuations
• Multi-purpose commodity chemicals exposed to Chinese overcapacity, and European assets carrying structural energy cost disadvantages, face a more difficult path

What playbooks are private equity investors using in Chemicals?

Three distinct playbooks are emerging for private equity investors positioning in Chemicals: building premium specialty platforms, pursuing corporate carve-outs and portfolio simplification, and executing operational restructurings in businesses where valuation expectations are resetting downward. Sustainability, meanwhile, is shifting from a narrative-led valuation premium toward a genuine test of economic competitiveness, particularly in consumer-facing and battery or energy storage applications.

With the sector approaching its cycle low and a growing number of private equity-held Chemicals assets ageing toward exit, disciplined investors with dry powder and sector conviction are well positioned to generate returns ahead of the recovery.

Keep reading

This article has been prepared solely for information purposes and is not intended to function as a “research report.” In particular, this means that it is not intended, nor does it contain sufficient information, to make a recommendation as to the advisability of investment in, or the value of, any security.   

Any link or reference to a third-party website contained in this article does not constitute an endorsement of any third-party content published on such website.

Additionally, this article does not constitute or form part of, and should not be construed as, an offer to sell, or a solicitation of any offer to buy, or any recommendation with respect to, any securities. You should not base any investment decision on this article; any investment involves risks, including the risk of loss, and you should not invest without speaking to a financial advisor. 

For additional important information regarding this article, please see insights and publications disclaimer.